Hjem › Bronkiekræft › Virginia
Bronkiekræft kliniske forsøg i Virginia
4 studier for Bronkiekræft søger deltagere på steder i Virginia.
Byer i Virginia
Officiel studietekst (engelsk)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Virginia Health System, Charlottesville
- USO - Virginia Cancer Specialists, Fairfax
- VCU Health Adult Outpatient Pavillion, Richmond
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- University of Virginia, Charlottesville
- Virginia Cancer Specialists, Fairfax
- Shenandoah Oncology, P.C., Winchester
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- VCU Medical Center (Virginia Commonwealth University), Richmond
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 26. jun. 2026 · NCT04614103Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.